Pathways linked to chemical carcinogenesis and proteoglycans in cancer highlight a potential disruption of extracellular matrix remodeling and receptor tyrosine kinase signaling, key drivers of tumor invasion [102,103,104,105,106]. The gene discussed is NTRK1; the disease is cancer.